Fig 1.
HSC: Health and Social Care; NHS: National Health Service.
Table 1.
Summary of identified polypharmacy management initiatives.
Table 2.
Summary of identified polypharmacy management initiatives (continued).
Fig 2.
Key informant interview characteristics.
1) The total number of key informants and the total number of profile characteristics are not equal, as more than one characteristic could be applied to the same key informant (e.g. one informant could be both a physician and a manager); 2) Those working in governing bodies or agencies overseeing health systems at a regional or national level; 3) Includes hospital CEO’s, primary care center directors, and department managers; 4) Geriatricians, hospitalists, general practitioners; 5) Hospital, primary care, and community; 6) Departments of pharmacy and medicine, also includes research and clinical faculty; 7) Medicine and pharmacy; 8) Patients and representatives of patient associations. UK: United Kingdom.
Fig 3.
Focus group participant characteristics.
1) The total number of key informants and the total number of profile characteristics are not equal, as more than one characteristic could be applied to the same key informant (e.g. one informant could be both a physician and a manager); 2) Those working in governing bodies or agencies overseeing health systems at a regional or national level; 3) Includes hospital CEO’s, primary care center directors, and department managers; 4) Geriatricians, hospitalists, general practitioners; 5) Hospital, primary care, and community; 6) Departments of pharmacy and medicine, also includes research and clinical faculty; 7) Medicine and pharmacy; 8) Patients and representatives of patient associations. UK: United Kingdom.
Table 3.
Major themes categorized by NPT and Kotter.